|
|
|
|
LEADER |
02426 am a22002653u 4500 |
001 |
103862 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Molavian, Hamid R.
|e author
|
100 |
1 |
0 |
|a Harvard University-
|e contributor
|
100 |
1 |
0 |
|a Sengupta, Shiladitya
|e contributor
|
700 |
1 |
0 |
|a Goldman, Aaron
|e author
|
700 |
1 |
0 |
|a Phipps, Colin J.
|e author
|
700 |
1 |
0 |
|a Kohandel, Mohammad
|e author
|
700 |
1 |
0 |
|a Wouters, Bradly G.
|e author
|
700 |
1 |
0 |
|a Sengupta, Shiladitya
|e author
|
700 |
1 |
0 |
|a Sivaloganathan, Sivabal
|e author
|
245 |
0 |
0 |
|a Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects
|
260 |
|
|
|b Springer Nature,
|c 2016-08-08T14:57:53Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/103862
|
520 |
|
|
|a Pharmacological concentrations of small molecule natural products, such as ascorbic acid, have exhibited distinct cell killing outcomes between cancer and normal cells whereby cancer cells undergo apoptosis or necrosis while normal cells are not adversely affected. Here, we develop a mathematical model for ascorbic acid that can be utilized as a tool to understand the dynamics of reactive oxygen species (ROS) induced cell death. We determine that not only do endogenous antioxidants such as catalase contribute to ROS-induced cell death, but also cell membrane properties play a critical role in the efficacy of ROS as a cytotoxic mechanism against cancer cells vs. normal cells. Using in vitro assays with breast cancer cells, we have confirmed that cell membrane properties are essential for ROS, in the form of hydrogen peroxide (H[subscript 2]O[subscript 2]), to induce cell death. Interestingly, we did not observe any correlation between intracellular H[subscript 2]O[subscript 2] and cell survival, suggesting that cell death by H[subscript 2]O[subscript 2] is triggered by interaction with the cell membrane and not necessarily due to intracellular levels of H[subscript 2]O[subscript 2]. These findings provide a putative mechanistic explanation for the efficacy and selectivity of therapies such as ascorbic acid that rely on ROS-induced cell death for their anti-tumor properties.
|
520 |
|
|
|a Natural Sciences and Engineering Research Council of Canada (NSERC discovery grant)
|
520 |
|
|
|a Natural Sciences and Engineering Research Council of Canada (NSERC/CIHR Collaborative Health Research grant)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Scientific Reports
|